Navigation Links
Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007
Date:2/11/2008

ense 2,402 2,489

Net income $17,718 $15,703

Basic net income per share $0.62 $0.59

Condensed Consolidated Statements of Cash Flows

Years ended December 31, 2007 and 2006

(Dollar amounts in thousands, except per share data)

Unaudited 2007 2006

Net cash provided by operating

activities $115,534 $75,586

Cash flows from investing activities:

Proceeds from investments sold or

matured:

Securities available for sale:

Fixed maturities sold 299,561 51,519

Fixed maturities matured 41,248 32,826

Equity securities 1,000 1,209

Securities held to maturity:

Fixed maturities matured 13,246 492

Acquisition of investments:

Securities available for sale:

Fixed maturities (327,409) (81,496)

Equity securities (18,379) (11,620)

Securities held to maturity:

Fixed maturities (8,244) (2,197)

Acquisition of business, net of

$10,403 of cash acquired 0 (27,793)

Net disbursements for policy loans (287) (415)

Capital expenditures (9,390) (11,873)

Other 0 2

Net cash used in investing

activities (8,654) (49,346)

Cash flows from financing acti
'/>"/>

SOURCE Triple-S Management Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Triple-S Management Corporation Announces Full Exercise of Underwriters Over-Allotment Option
2. Triple-S Management Corporation to Present at UBS Global Healthcare Conference
3. Case Management Cost-Effective Way to Cut Heart Risks
4. S.C. BlueCross to Integrate Care Management with Personal Health Record in Real Time
5. Marlabs in the Top 10 BPO Healthcare Revenue Cycle Management Companies
6. Painless Hemorrhoid Treatment Adds Management Punch
7. HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming
8. Judge Rules That Florida Disease Management Program Serving 8,000 HIV/AIDS Patients Should Be Re-bid, Says AIDS Healthcare Foundation
9. Standard Management Announces OTCBB Listing
10. MDS Pharma Services Wins Award for Management of Global Malaria Trial
11. AWT Management Announce Aggressive Growth and Acquisition Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 3Indiana Blood Center Taps tw telecom for Data, Internet and IP Telephony Services 2National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 1Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 2Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 3Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 4Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 5Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 6Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 7Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 8Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 9Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 10Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 11Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 12Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 13Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 14Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 15Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 16MarketsandMarkets 3A Global Stem Cell and Advanced Technologies Market Worth US 24 88 3 Billion By 2014 14699 1MarketsandMarkets 3A Global Stem Cell and Advanced Technologies Market Worth US 24 88 3 Billion By 2014 14699 2MarketsandMarkets 3A Global Stem Cell and Advanced Technologies Market Worth US 24 88 3 Billion By 2014 14699 3Experimental Stem Cell Therapy Raises Hope for Pulmonary Fibrosis Patients 14698 1Experimental Stem Cell Therapy Raises Hope for Pulmonary Fibrosis Patients 14698 2Experimental Stem Cell Therapy Raises Hope for Pulmonary Fibrosis Patients 14698 3